Company intelligence / Profile preview

ZenZen Biotech

Taipei, Taipei City, Taiwan
Ownership
Private
Development stage
Other
01

Overview

Zen-Zen Biotech is a Taiwan-based biotechnology company specializing in cell therapy and regenerative medicine. Founded in 2019 and renamed in 2022, the company operates a Good Tissue Practice (GTP) compliant laboratory to develop advanced cellular products, including cytokine-induced killer (CIK) cells and various stem cell therapies. Its lead program is a Phase 1 clinical trial evaluating autologous CIK cells in combination with chemotherapy for stage IV non-small cell lung cancer. Additionally, Zen-Zen Biotech provides cell storage services for umbilical cord and adipose-derived mesenchymal stem cells and is actively researching exosome-based therapeutics. The company collaborates with major Taiwanese hospitals and academic institutions to advance its clinical pipeline and therapeutic offerings.

Therapeutic areas
OncologyWomen's Health
Modalities
Cell therapyStem cell therapyExosome-based therapy
Industry
Biotech
02

Drug pipeline

2 assets

Wharton's jelly-derived mesenchymal stem cells (Zen-Zen Biotech)

Preclinical

1 more asset in the full pipeline.

Request access →
03

Partnerships

Shin Kong Wu Ho-Su Memorial HospitalCathay General HospitalBuddhist Chengte HospitalNational Tsing Hua University

Beyond the preview

Go deeper on ZenZen Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZenZen Biotech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call